Moving genomics closer to the clinic

The following is an excerpt of a longer story.

Foundation Medicine and Memorial Sloan-Kettering Cancer Center this month announced a partnership that aims to bring genomics further into the clinic and help to translate molecular information into personalized cancer treatment.

Foundation Medicine, a molecular information company on the forefront of bringing comprehensive cancer genomic analysis to routine clinical care, has provided its first product, the FoundationOne™ assay, to clinicians since June 2012. It uses next-generation sequencing (NGS) to interrogate hundreds of cancer related genes from routine tumor samples. Test results are provided in a report that aligns detected mutations with potentially relevant treatment options and clinical trials.

Read the full story here: Moving Genomics Closer to the Clinic

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend